Kathy D. Miller

Also affiliated with University of Indianapolis, Indiana Cancer Consortium, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.1Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772

Top 27%

0.742DataRank

Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Papers

Driven by 33 papers — median percentile 60. Top paper: “A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)”.

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2182

N/A

3.8DataRank · unranked

125 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772

Top 27%

0.742DataRank

Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.0254

N/A

0.488DataRank · unranked

7 citations

Anne O’Neill, Karen Sepucha, Kathy D. Miller, Chau T. Dang, Donald W. Northfelt +4 more

ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer

Journal of Clinical Oncology(2024)10.1200/jco.24.00526

N/A

0.442DataRank · unranked

11 citations

Fengmin Zhao, Tarah J. Ballinger, Sofia F. Garcia, Fei Shen, Shamsuddin Virani +19 more

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf088

Top 52%

0.329DataRank

Top 52%7 citations

Samuel M. Niman, Megumi Kai, Sean G. Ryan, Elizabeth Troll, Li Li +16 more

Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2–negative breast cancer: A trajectory analysis of adverse events

Cancer(2021)10.1002/cncr.33992

N/A

0.266DataRank · unranked

4 citations

Santiago Saldana, Kathy D. Miller, Ruth C. Carlos, Ilana F. Gareen, Joseph A. Sparano +9 more

Adjuvant platinum versus capecitabine for residual, invasive, triple‐negative breast cancer: Patient‐reported outcomes in ECOG‐ACRIN EA1131

Cancer(2024)10.1002/cncr.35187

N/A

0.208DataRank · unranked

3 citations

Fengmin Zhao, Ingrid A. Mayer, Amyé Tevaarwerk, Sofia F. Garcia, Carlos L. Arteaga +20 more

Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.29697

N/A

0DataRank · unranked

15 citations

Bradley S. Snyder, Ilana F. Gareen, Constance D. Lehman, Seema A. Khan, Justin Romanoff +7 more

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

Radiology(2021)10.1148/radiol.2021219016

N/A

0DataRank · unranked

5 citations

Justin Romanoff, Constance D. Lehman, Seema A. Khan, Ruth C. Carlos, Sunil Badve +17 more

A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.605

N/A

0DataRank · unranked

7 citations

Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette +12 more

Social determinants of health, genetic ancestry, and mortality in ECOG-ACRIN E5103.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6527

N/A

0DataRank · unranked

3 citations

Anne O’Neill, Kathy D. Miller, Bryan P. Schneider, Ann H. Partridge, Lava Timsina +4 more

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer in the ECOG-ACRIN 5103 trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.520

N/A

0DataRank · unranked

2 citations

Anne O’Neill, Noah Graham, Donald W. Northfelt, Chau T. Dang, Antonio C. Wolff +3 more

Reply to T. Shimoi et al and Y. Shimanuki et al

Journal of Clinical Oncology(2021)10.1200/jco.21.01905

N/A

0DataRank · unranked

2 citations

Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette +20 more

Engaging the radiology community in the National Clinical Trials Network: The ECOG-ACRIN TMIST experience.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps10609

N/A

0DataRank · unranked

0 citations

Constantine Gatsonis, Mitchell D. Schnall, Martin D. Yaffe, Melissa A. Troester, Ilana F. Gareen +8 more

Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients

JACC CardioOncology(2020)10.1016/j.jaccao.2020.09.001

N/A

0DataRank · unranked

50 citations

Emerson C. Perin, James T. Willerson, Phillip C. Yang, Jay H. Traverse, Timothy D. Henry +29 more

Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3078

N/A

0DataRank · unranked

29 citations

Jeffrey P. Solzak, Chao J. Wang, Bradley A. Hancock, Sunil Badve, Sandra K. Althouse +6 more

Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer

npj Breast Cancer(2022)10.1038/s41523-021-00376-9

N/A

0DataRank · unranked

27 citations

Anne O’Neill, Noah Graham, Donald W. Northfelt, Chau T. Dang, Antonio C. Wolff +3 more

Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)

Cancer(2022)10.1002/cncr.34173

N/A

0DataRank · unranked

13 citations

Guanglong Jiang, Fei Shen, Kathy D. Miller, George W. Sledge, Bryan P. Schneider +1 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of Oncology(2023)10.1016/j.annonc.2023.08.004

N/A

0DataRank · unranked

58 citations

Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7045

N/A

0DataRank · unranked

10 citations

Helga S. Marques, Gloria Xue, Richard L. Hoffman, Constantine Gatsonis, Fengmin Zhao +4 more

Cytochrome P450 Oxidoreductase ( POR ) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2431

N/A

0DataRank · unranked

5 citations

Guanglong Jiang, Santosh Philips, Laura Gardner, Gloria Xue, Erica Cantor +10 more

Incidence round screening performance among women with dense breasts undergoing abbreviated breast MRI and digital breast tomosynthesis (ECOG-ACRIN EA1141).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10502

N/A

0DataRank · unranked

7 citations

Constantine Gatsonis, Gillian M. Newstead, Bradley S. Snyder, Na An, Ilana F. Gareen +13 more

Data from A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

(2023)10.1158/1078-0432.c.6530837

N/A

0DataRank · unranked

0 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

Data from Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532511.v1

N/A

0DataRank · unranked

0 citations

Jeffrey P. Solzak, Chao J. Wang, Bradley A. Hancock, Sunil Badve, Sandra K. Althouse +6 more

Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE

British Journal of Cancer(2024)10.1038/s41416-024-02602-0

N/A

0DataRank · unranked

0 citations

Guanglong Jiang, Santosh Philips, Erica Cantor, Laura Gardner, Gloria Xue +9 more

ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer

Cancer Research(2025)10.1158/0008-5472.can-24-1286

N/A

0DataRank · unranked

8 citations

Rachel Abbotts, Kaushlendra Tripathi, Collin M. Coon, Saranya Rajendran, Elnaz Abbasi Farid +26 more

Predictors of surgery preference and quality of life in DCIS after breast MRI: A trial of the ECOG-ACRIN Cancer Research Group (E4112).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6564

N/A

0DataRank · unranked

0 citations

Bradley S. Snyder, Ilana F. Gareen, Constance D. Lehman, Seema A. Khan, Justin Romanoff +14 more

Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1073

N/A

0DataRank · unranked

32 citations

Megan Othus, Sandip Pravin Patel, Young Kwang Chae, Kathy D. Miller, Rashmi Chugh +8 more

Predictive value of bother by side effects of treatment prior to protocol therapy for early treatment discontinuation in clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e19132

N/A

0DataRank · unranked

3 citations

John Devin Peipert, Ju‐Whei Lee, Fangxin Hong, Edward H. Ip, Ilana F. Gareen +15 more

ECOG-ACRIN tomosynthesis mammographic imaging screening trial (EA1151).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps1597

N/A

0DataRank · unranked

1 citations

Constantine Gatsonis, Martin J. Yaffe, Melissa A. Troester, Ilana F. Gareen, Laura C. Collins +6 more

Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase

Cancer Letters(2021)10.1016/j.canlet.2021.03.026

N/A

0DataRank · unranked

57 citations

Deren Li, Jacob A. Danielson, Evan H. Zhang, Zizheng Dong, Kathy D. Miller +4 more

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

Radiology(2021)10.1148/radiol.2021204743

N/A

0DataRank · unranked

38 citations

Justin Romanoff, Constance D. Lehman, Seema A. Khan, Ruth C. Carlos, Sunil Badve +17 more

RETRACTED: Targeted immunotherapy for HER2-low breast cancer with 17p loss

Science Translational Medicine(2021)10.1126/scitranslmed.abc6894

N/A

0DataRank · unranked

34 citations

Yifan Sun, Michael Kulke, Torsten Hechler, Kevin Van der Jeught, Tianhan Dong +8 more

Kathy D. Miller

Indexed papers

Top data-sharing exemplar

Papers